Degassing Device and End-Cap Assembly for a Filter Including Such a Degassing Device
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/EP2010/054267, filed Mar 31, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,048,209 | Degassing Device and End-Cap Assembly for a Filter Including Such a Degassing Device In force · High confidence UsedRemaining | Gambro Lundia AB | In force | High confidence | ||
| US 8,206,580 | Integrated Blood Treatment Module In force · High confidence | Gambro Lundia AB | In force | High confidence | ||
| US 8,113,060 | Pressure Sensing Device and Use of the Same in a Connecting Structure In force · High confidence | Gambro Lundia AB | In force | High confidence | ||
| US 8,197,460 | Multicompartment Container Containing a Medical Solution In force · High confidence | Gambro Lundia AB | In force | High confidence | ||
| US 8,652,082 | Blood Treatment Apparatus In force · High confidence | Gambro Lundia AB | In force | High confidence | ||
| US 8,870,804 | Blood Treatment Apparatus and Method In force · High confidence | Gambro Lundia AB | In force | High confidence | ||
| US 9,446,181 | Method to Treat Blood by Controlling Blood Pumps with Fluid Pumps In force · Medium confidence | Gambro Lundia AB | In force | Medium confidence | ||
| US 8,911,390 | Multipart Fluid System and a System for Regional Citrate Anticoagulation in an Extracorporeal Blood Circuit In force · High confidence | Gambro Lundia AB | In force | High confidence | ||
| US 9,486,570 | Multipart Fluid System and a System for Regional Citrate Anticoagulation in an Extracorporeal Blood Circuit In force · Medium confidence | Gambro Lundia AB | In force | Medium confidence | ||
| US 10,709,833 | Multipart Fluid System and a System for Regional Citrate Anticoagulation in an Extracorporeal Blood Circuit In force · Medium confidence | Gambro Lundia AB | In force | Medium confidence | ||
| 10 more records in this group · Pro | ||||||
10 of 20 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 20, including 2 expired and 2 expiring within the 18 months from Nov 21, 2026.
16 of these are in force and held by Gambro Lundia AB.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.